Amy Wynn
Nurse Practitioner · Decatur, ALNPI 1689985152
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 432 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 31.3% of the total. Reporting peaked in 2022 at $2,889 and has fallen 63.6% since, to $1,053 in 2023. Among nurse practitioner clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 432 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- AbbVie$1K
- Johnson & Johnson$781
- Takeda Pharmaceuticals U.S.A., Inc.$608
- QOL Medical, LLC$306
- Ironwood Pharmaceuticals, Inc$255
- plus $1K from 12 others
What the payments were for
- Food & beverage$6,43198%
- Education$1642%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 186 | $2,062 |
| AbbVie | 82 | $1,431 |
| Johnson & Johnson | 37 | $781 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $608 |
| QOL Medical, LLC | 13 | $306 |
| Ironwood Pharmaceuticals, Inc | 15 | $255 |
| Redhill Biopharma Inc. | 14 | $232 |
| Ferring Pharmaceuticals Inc. | 8 | $177 |
| Gilead | 7 | $129 |
| Merck | 6 | $102 |
| Regeneron Healthcare Solutions, Inc. | 5 | $91 |
| Bristol Myers Squibb | 5 | $83 |
| Nestle Healthcare Nutrition Inc. | 5 | $82 |
| Sanofi | 4 | $82 |
| Intra-sana Laboratories | 2 | $48 |
| Intercept Pharmaceuticals, Inc. | 3 | $48 |
| Braintree Laboratories, Inc. | 3 | $45 |
| Pfizer | 2 | $33 |
How this compares
$6,594 in reported general payments places this provider in the 90th percentile of 1,505 nurse practitioner providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 16 | $222 |
| Omeprazole | 14 | $139 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Decatur
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$29K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
- Ashley HodgensMontgomery$19K
- Lisa PeoplesBirmingham$17K
- Samantha WeaverBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.